Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Marion Wiesmann
CHIR-258, a Novel, Multitargeted Tyrosine Kinase Inhibitor for the Potential Treatment of T(4;14) Multiple Myeloma
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Related publications
In Vivo Target Modulation and Biological Activity of CHIR-258, a Multitargeted Growth Factor Receptor Kinase Inhibitor, in Colon Cancer Models
Clinical Cancer Research
Cancer Research
Oncology
Multitargeted Therapies for Multiple Myeloma
Autophagy
Cell Biology
Molecular Biology
Diagnostic Evaluation of T(4;14) in Multiple Myeloma and Evidence for Clonal Evolution
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Kinase Inhibitors as Potential Agents in the Treatment of Multiple Myeloma
Oncotarget
Oncology
Novel Drugs for the Treatment of Multiple Myeloma
Haematologica
Hematology
A Phase I Study of E7080, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Advanced Solid Tumours
British Journal of Cancer
Cancer Research
Oncology
Targeting C-Met Receptor Tyrosine Kinase by the DNA Aptamer SL1 as a Potential Novel Therapeutic Option for Myeloma
Journal of Cellular and Molecular Medicine
Molecular Medicine
Cell Biology
Hsa_circ_0007841: A Novel Potential Biomarker and Drug Resistance for Multiple Myeloma
Frontiers in Oncology
Cancer Research
Oncology
Treatment of Multiple Myeloma With VLA4-targeted Nanoparticles Delivering Novel C-Myc Inhibitor Prodrug